Kineta
Biotechnology ResearchWashington, United States11-50 Employees
Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives.
Insights
Innovative Immunotherapies Kineta specializes in next-generation immunotherapies for cancer, presenting opportunities to offer advanced biopharmaceutical manufacturing, clinical development services, or specialized research tools tailored to immunotherapy projects.
Clinical Trial Expansion The company is actively progressing multiple Phase 1/2 clinical trials, including VISTA-101 and KVA12123, indicating a potential need for clinical research support, trial management solutions, and biostatistics services.
Partnership & Collaborations Recent collaborations with hardware partners for EV charging solutions suggest an openness to strategic partnerships, opening doors for cross-sector technology integrations, research collaborations, or joint development initiatives.
Financial Growth Stage With revenues between 10 to 25 million dollars and recent funding of 15 million dollars, Kineta is in a growth phase, presenting opportunities for investment, licensing negotiations, or advanced research tool sales to support their expanding pipeline.
Market Positioning As a clinical-stage biotech comparable to companies like Affimed and Aligos Therapeutics, Kineta's focus on immunotherapy novel approaches makes it a strategic target for companies offering complementary technology, diagnostics, or specialty contract research services.
Similar companies to Kineta
Anavex Life Sciences
$10M$25MAffimed Therapeutics AG
$1M$10MAligos Therapeutics
$10M$25MAnnexon Biosciences
$50M$100MAN2 Therapeutics
$10M$25MAmgen
$10BApplied Molecular Transport
$10M$25MAlterity Therapeutics
$1M$10MAmbys Medicines
$1M$10M
Kineta Tech Stack
Kineta uses 8 technology products and services including MySQL, Twemoji, particles.js, and more. Explore Kineta's tech stack below.
- MySQLDatabase
- TwemojiFont Scripts
- particles.jsJavascript Graphics
- Headroom.jsJavascript Libraries
- ModernizrJavascript Libraries
- Yoast SEOSearch Engines
- BootstrapUI Frameworks
- TwitterWidgets
Media & News
Kineta's Email Address Formats
Kineta uses at least 2 format(s):
| Kineta Email Formats | Percentage |
| FLast@kineta.us | 90% |
| First@kineta.us | 5% |
| LFirst@kineta.us | 5% |
| FLast@kinetabio.com | 49% |
| First@kinetabio.com | 1% |
| FirstLast@kinetabio.com | 1% |
| FLast@kinetabio.com | 49% |
Frequently Asked Questions
Where is Kineta's headquarters located?
Kineta's main headquarters is located at Seattle, Washington United States. The company has employees across 3 continents, including North AmericaAsiaSouth America. What is Kineta's phone number?
You can contact Kineta's main corporate office by phone at +1-206-378-****
What is Kineta's stock symbol?
Kineta is a publicly traded company; the company's stock symbol is KA. What is Kineta's official website and social media links?
Kineta's official website is kinetabio.com and has social profiles on LinkedIn.How much revenue does Kineta generate?
As of February 2026, Kineta's annual revenue is estimated to be $4.3M. What is Kineta's SIC code NAICS code?
Kineta's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Kineta have currently?
As of February 2026, Kineta has approximately 30 employees across 3 continents, including North AmericaAsiaSouth America. Key team members include Vice President Of Business Development: B. J.President And Chief Operating Officer: R. H.Senior Vice President, Translational Development: E. T.. Explore Kineta's employee directory with LeadIQ.What technology does Kineta use?
Kineta's tech stack includes MySQLTwemojiparticles.jsHeadroom.jsModernizrYoast SEOBootstrapTwitter. What is Kineta's email format?
Kineta's email format typically follows the pattern of FLast@kineta.us. Find more Kineta email formats with LeadIQ. How much funding has Kineta raised to date?
As of February 2026, Kineta has raised $15M in funding. The last funding round occurred on Jun 01, 2021 for $10M.When was Kineta founded?
Kineta was founded in 2008.
Company Overview
- Headquarters
- Seattle, Washington United States
- Phone number
- +1-206-378-****
- Website
- kinetabio.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- KA
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2008
- Employees
- 11-50
Media & News
Funding & Financials
- $15M
Kineta has raised a total of $15M of funding over 2 rounds. Their latest funding round was raised on Jun 01, 2021 in the amount of $10Mas a financing round.
- $10M$25M
Kineta's revenue is estimated to be in the range of $10M$25M
Funding & Financials
- $15M
Kineta has raised a total of $15M of funding over 2 rounds. Their latest funding round was raised on Jun 01, 2021 in the amount of $10Mas a financing round.
- $10M$25M
Kineta's revenue is estimated to be in the range of $10M$25M
Company Leadership
B. J.Vice President Of Business Development
R. H.President And Chief Operating Officer- E. T.Senior Vice President, Translational Development
K. W. O.Director- P. P.Manager
Employee Directory
- R. K.Manager
- D. H.Principal
- J. S.Principal
- J. C.Member
- M. C.Research Assistant
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
